GL1X · GenesisL1 explorer

Research workbench

Oxa-48 in complex with compound 24

Analyse Oxa-48 in complex with compound 24 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5QAT
Type
protein
Length
971 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q6XEC0
Ligands
T7O, CL
Pockets
6 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein24240% helix, 21% strandQ6XEC0
B, C, DBeta-lactamase (EC 3.5.2.6)protein24340% helix, 21% strandQ6XEC0

Ligands and binding sites

  • T7O · 3-[3-(acetyloxymethyl)phenyl]benzoic acid · ligand · 4 copies · chains A, B, C, D
  • CL · Chloride ion · ion · 2 copies · chains A, D, C
  • EDO · 1,2-ethanediol · additive · 5 copies · chains C, A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15930.790.8586CL, EDO
29540.790.8188empty
38630.760.7999T7O
41960.460.7434T7O
5510.380.8117empty

Interfaces

4 interfaces between chains.

  • A–D · 995 Ų buried · 21 hydrogen bonds · protein-protein
  • A–C · 504 Ų buried · 5 hydrogen bonds · protein-protein
  • B–C · 442 Ų buried · 10 hydrogen bonds · protein-protein
  • A–B · 224 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (carboxylation).

Compared structures

  • 5QAT · Oxa-48 in complex with compound 24 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.